home / stock / athx / athx quote
Last: | $0.1018 |
---|---|
Change Percent: | -37.41% |
Open: | $0.1348 |
Close: | $0.1018 |
High: | $0.1348 |
Low: | $0.0982 |
Volume: | 78,968,068 |
Last Trade Date Time: | 10/17/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.1018 | $0.1348 | $0.1018 | $0.1348 | $0.0982 | 78,968,068 | 10-17-2023 |
$0.0981 | $0.1056 | $0.0981 | $0.1098 | $0.0938 | 16,245,002 | 10-16-2023 |
$0.1028 | $0.11 | $0.1028 | $0.13 | $0.1015 | 11,056,464 | 10-13-2023 |
$0.119 | $0.127 | $0.119 | $0.1444 | $0.1126 | 11,045,745 | 10-12-2023 |
$0.1395 | $0.1484 | $0.1395 | $0.165 | $0.12 | 59,132,094 | 10-11-2023 |
$0.12 | $0.1264 | $0.12 | $0.18 | $0.1051 | 21,971,841 | 10-10-2023 |
$0.3 | $0.31 | $0.3 | $0.329 | $0.2748 | 621,797 | 10-09-2023 |
$0.3022 | $0.36 | $0.3022 | $0.3797 | $0.2932 | 1,306,924 | 10-06-2023 |
$0.3285 | $0.4268 | $0.3285 | $0.44 | $0.29847 | 1,017,855 | 10-05-2023 |
$0.44 | $0.4376 | $0.44 | $0.4599 | $0.3982 | 266,523 | 10-04-2023 |
$0.4376 | $0.442 | $0.4376 | $0.4499 | $0.3961 | 370,318 | 10-03-2023 |
$0.421 | $0.4352 | $0.421 | $0.439899 | $0.404 | 429,868 | 10-02-2023 |
$0.4321 | $0.4501 | $0.4321 | $0.4501 | $0.376 | 840,191 | 09-29-2023 |
$0.358 | $0.3443 | $0.358 | $0.3619 | $0.32 | 184,530 | 09-28-2023 |
$0.3274 | $0.3495 | $0.3274 | $0.3589 | $0.3105 | 268,075 | 09-27-2023 |
$0.332 | $0.3145 | $0.332 | $0.355 | $0.29 | 575,664 | 09-26-2023 |
$0.3015 | $0.32 | $0.3015 | $0.32 | $0.29 | 85,953 | 09-25-2023 |
$0.291 | $0.282 | $0.291 | $0.31 | $0.282 | 223,886 | 09-22-2023 |
$0.282 | $0.3016 | $0.282 | $0.331 | $0.28 | 237,242 | 09-21-2023 |
$0.3033 | $0.3205 | $0.3033 | $0.3396 | $0.3027 | 153,321 | 09-20-2023 |
News, Short Squeeze, Breakout and More Instantly...
Athersys, Inc. (OTC: ATHX), a regenerative medicine company developing MultiStem ® (invimestrocel) cell therapy for critical care indications, announced financial results for the three and nine months ended September 30, 2023 and provided a business update. Third Quarter 2023 and...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million pri...